Caring for Your Skin and Body During GLP-1 Weight Loss
A GLP-1 medication changes how much you eat. What you eat, how you move and how you care for your skin decide how you look and feel at the end.
How GLP-1 medications interact with hormones, fertility and the pill, including the tirzepatide oral contraceptive warning and pregnancy planning advice.
There’s a line in the tirzepatide prescribing information that many patients never see, and it’s one of the first things I point out when a woman of reproductive age starts treatment: the medication may make oral birth control pills less effective. Combine that with the way weight loss itself can restore fertility, and you have a setup for surprises.
This article covers how GLP-1 medications interact with hormones, what the contraception guidance says, how to plan around pregnancy, and what men should know too.
Excess body fat, particularly with insulin resistance, changes hormone balance. In women, it can disrupt ovulation and cycle regularity. In men, it is associated with lower testosterone, partly because fat tissue converts testosterone into estrogen and partly through effects on the brain’s hormone signaling.
When people lose meaningful weight, many of these changes reverse. Women may begin ovulating more regularly. Men with obesity-related low testosterone often see their levels rise. That’s generally good news — but it means fertility can change faster than people expect.
GLP-1 medications slow the emptying of the stomach, which can affect how some oral medications are absorbed. For tirzepatide, studies found that this effect could reduce the absorption of oral hormonal contraceptives, especially after a dose change.
The tirzepatide labeling advises women using oral contraceptives to either:
Semaglutide studies did not show the same clinically meaningful effect on the pill. Even so, vomiting or severe diarrhea from any cause can reduce the pill’s reliability, so the usual backup rules apply if you’re sick.
GLP-1 medications are not recommended during pregnancy, because weight loss offers no benefit in pregnancy and animal studies raised concerns. The safety data in human pregnancy are limited.
Breastfeeding is another gray area; there isn’t enough data to recommend GLP-1 medications while nursing, and that decision should involve your obstetric and pediatric providers.
For men, GLP-1-related weight loss may improve testosterone levels when low testosterone is driven by obesity. I often recommend addressing weight and sleep before starting testosterone therapy in this situation, because testosterone treatment itself can suppress sperm production. We don’t have strong data suggesting that GLP-1 medications harm male fertility, but research is limited, and men actively trying to conceive should discuss timing with their doctor.
Many women in perimenopause or menopause use hormone therapy, and many ask whether it’s safe to combine with a GLP-1. In general, transdermal and vaginal hormone products aren’t affected by stomach emptying the way oral pills can be. Oral hormones, thyroid medication and other drugs with a narrow dosing window may need closer monitoring. Baseline and follow-up lab work help us adjust safely.
These medications are not appropriate during pregnancy, or for people with a personal or family history of medullary thyroid cancer or MEN2. Use caution with a history of pancreatitis, gallbladder disease, or severe GI conditions. Seek medical care for severe abdominal pain or persistent vomiting.
Studies did not show a clinically meaningful effect, but vomiting or diarrhea can reduce pill effectiveness, so use backup protection when sick.
The labeling advises a barrier method for four weeks after starting and four weeks after each dose increase, or switching to a non-oral method.
Weight loss can restore ovulation in some women, which can raise the chance of pregnancy. Plan contraception accordingly.
Semaglutide labeling advises at least two months before a planned pregnancy. Ask your prescriber about your specific medication.
Our medical weight loss program considers your reproductive plans from the first visit. Schedule a complimentary, no-commitment consultation with our team, supervised by me.
Ask about Easy Pay financing.
References: Tirzepatide injection prescribing information. U.S. FDA labeling. · Semaglutide injection prescribing information. U.S. FDA labeling. · U.S. Food and Drug Administration
This article is for general information only and is not medical advice. Treatments are provided only after consultation and evaluation by a licensed provider. Individual results vary.

A GLP-1 medication changes how much you eat. What you eat, how you move and how you care for your skin decide how you look and feel at the end.
Losing weight quickly can leave the face looking older than you feel. Here’s why “GLP-1 face” happens, how to limit it, and the treatments that can help.
For many women with PCOS, weight and insulin resistance are the hardest parts to manage. Here’s where GLP-1 medications fit, and the precautions that matter most.